| Plasma homocysteine, folate and vitamin B12 levels in patients with lung cancer D Taştekin, K Ertürk, HU Bozbey, O Ölmüşçelik, HŞ Kızıltan, S Tuna, F Taş Experimental oncology, 2015 | 61 | 2015 |
| Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors F Tas, K Erturk Melanoma Research 27 (2), 134-139, 2017 | 49 | 2017 |
| Comparison of risk factors for cardiovascular disease in hemodialysis and peritoneal dialysis patients O Harmankaya, N Akalin, H Akay, Y Okuturlar, K Erturk, H Kaptanogullari, ... Clinics 70, 601-605, 2015 | 38 | 2015 |
| Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer F Tas, E Bilgin, D Tastekin, K Erturk, D Duranyildiz Biomedical reports 4 (5), 609-614, 2016 | 33 | 2016 |
| Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma F Tas, K Erturk Molecular and clinical oncology 7 (6), 1142-1146, 2017 | 32 | 2017 |
| Presence of histological regression as a prognostic factor in cutaneous melanoma patients F Tas, K Erturk Melanoma Research 26 (5), 492-496, 2016 | 30 | 2016 |
| Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival F Tas, K Erturk Molecular and clinical oncology 7 (6), 1083-1088, 2017 | 29 | 2017 |
| Scalp melanoma is associated with high mitotic rate and is a poor prognostic factor for recurrence and outcome F Tas, K Erturk Melanoma Research 27 (4), 387-390, 2017 | 27 | 2017 |
| Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome H Karanlik, I Ozgur, N Cabioglu, F Sen, K Erturk, B Kilic, S Onder, M Deniz, ... European Journal of Surgical Oncology (EJSO) 41 (9), 1226-1233, 2015 | 27 | 2015 |
| Tumor infiltrating lymphocytes (TILs) may be only an independent predictor of nodal involvement but not for recurrence and survival in cutaneous melanoma patients F Tas, K Erturk Cancer Investigation 35 (8), 501-505, 2017 | 26 | 2017 |
| Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer K Erturk, D Tastekin, M Serilmez, E Bilgin, HU Bozbey, S Vatansever Tumor Biology 37, 405-412, 2016 | 25 | 2016 |
| Clinical significance of circulating serum cellular heat shock protein 90 (HSP90) level in patients with cutaneous malignant melanoma F Tas, E Bilgin, K Erturk, D Duranyildiz Asian Pacific Journal of Cancer Prevention: APJCP 18 (3), 599, 2017 | 23 | 2017 |
| Acral lentiginous melanoma is associated with certain poor prognostic histopathological factors but may not be correlated with nodal involvement, recurrence, and a worse survival F Tas, K Erturk Pathobiology 85 (4), 227-231, 2018 | 21 | 2018 |
| Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior? K Erturk, S Karaman, N Dagoglu, M Serilmez, D Duranyildiz, F Tas Wiener klinische Wochenschrift 131, 419-426, 2019 | 20 | 2019 |
| Assessment of anxiety and depression status in Turkish cutaneous melanoma patients F Tas, S Karabulut, H Guveli, S Kurul, K Erturk, M Guveli, H Kinik Asian Pacific journal of cancer prevention: APJCP 18 (2), 369, 2017 | 19 | 2017 |
| BRAF V600E mutation as a prognostic factor in cutaneous melanoma patients F Tas, K Erturk Dermatologic therapy 33 (2), e13270, 2020 | 18 | 2020 |
| Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma F Tas, K Erturk International Journal of Dermatology 56 (2), 166-170, 2017 | 17 | 2017 |
| The efficacy of Pistacia Terebinthus soap in the treatment of cetuximab-induced skin toxicity D Tastekin, M Tambas, K Kilic, K Erturk, D Arslan Investigational new drugs 32, 1295-1300, 2014 | 17 | 2014 |
| Clinical significance of serum galectin-3 levels in gastric cancer patients F Tas, E Bilgin, D Tastekin, K Erturk, D Duranyildiz Journal of gastrointestinal cancer 47, 182-186, 2016 | 16 | 2016 |
| Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers? K Erturk, D Tastekin, E Bilgin, M Serilmez, HU Bozbey, B Sakar Biomedicine & Pharmacotherapy 77, 86-91, 2016 | 15 | 2016 |
